Outcome measures in juvenile X-linked retinoschisis: A systematic review

被引:14
|
作者
Grigg, John R. [1 ,2 ,3 ]
Hooper, Claire Y. [1 ,2 ]
Fraser, Clare L. [1 ,2 ,3 ]
Cornish, Elisa E. [1 ,2 ,3 ]
McCluskey, Peter J. [1 ,2 ,3 ]
Jamieson, Robyn V. [1 ,2 ,4 ]
机构
[1] Save Sight Inst, Fac Med & Hlth, Discipline Clin Ophthalmol & Eye Hlth, 8 Macquarie St, Sydney, NSW 2001, Australia
[2] Univ Sydney, Childrens Med Res Inst, Save Sight Inst, Eye Genet Res,Childrens Hosp Westmead, Sydney, NSW, Australia
[3] Sydney Eye Hosp, Macquarie St, Sydney, NSW, Australia
[4] Univ Sydney, Sydney Med Sch, Disciplines Genet Med & Child & Adolescent Hlth, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
CYSTIC MACULAR LESIONS; VISUAL-ACUITY; PHENOTYPIC-EXPRESSION; TOPICAL DORZOLAMIDE; IMPACT; GENOTYPE; MUTATIONS; FAMILIES; TRIALS; SIZE;
D O I
10.1038/s41433-020-0848-6
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
X-linked retinoschisis (XLRS) is a leading cause of hereditary juvenile macular degeneration in males resulting in significant vision impairment. Outcome measures to monitor disease progression or therapeutic interventions have evolved with technology. A systematic review was undertaken to evaluate outcome measures for XLRS. Inclusion criteria were all publications examining outcome measures for natural history studies or following an interventional approach for patients with XLRS. Studies which did not present follow-up data were excluded. We searched medical databases including CENTRAL, Ovid Medline, pre-Medline and ahead of Print up to February 2019. Two authors independently assessed the risk of bias. Twelve studies meet the inclusion criteria with four prospective and eight retrospective case series. Five series were natural history observational studies and seven were interventional series using either topical or systemic carbonic anhydrase inhibitors. Visual acuity (VA) declined very slowly in the natural history studies equivalent to 0.22-0.5 letters per year. Five of the six interventional studies showed an improvement in VA and four a reduction in spectral domain optical coherence tomography (SD-OCT) parameters for central macular thickness (CMT). The full-field electroretinogram identified the 30-Hz latency as a further parameter to monitor function. VA was the measure most likely to show a statistically significant outcome. How functionally meaningful this is, requires further evaluation. CMT SD-OCT outcomes are variable depending on cystic changes. More refined measures are required to better correlate structure with function.
引用
收藏
页码:1760 / 1769
页数:10
相关论文
共 50 条
  • [21] X-Linked Retinoschisis Novel Clinical Observations and Genetic Spectrum in 340 Patients
    Hahn, Leo C.
    Schooneveld, Mary J. van
    Wesseling, Nieneke L.
    Florijn, Ralph J.
    Brink, Jacoline B. ten
    Lissenberg-Witte, Birgit I.
    Strubbe, Ine
    Meester-Smoor, Magda A.
    Thiadens, Alberta A.
    Diederen, Roselie M.
    van Cauwenbergh, Caroline
    de Zaeytijd, Julie
    Walraedt, Sophie
    de Baere, Elfride
    Klaver, Caroline C. W.
    Norel, Jeannette Ossewaarde-van
    Born, L. Ingeborgh van den
    Hoyng, Carel B.
    Genderen, Maria M. van
    Sieving, Paul A.
    Leroy, Bart P.
    Bergen, Arthur A.
    Boon, Camiel J. F.
    OPHTHALMOLOGY, 2022, 129 (02) : 191 - 202
  • [22] Clinical manifestation and genetic analysis in Chinese early onset X-linked retinoschisis
    Huang, Li
    Sun, Limei
    Wang, Zhirong
    Chen, Chonglin
    Wang, Panfeng
    Sun, Wenmin
    Luo, Xiaoling
    Ding, Xiaoyan
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (10):
  • [23] Structure/Psychophysical Relationships in X-Linked Retinoschisis
    Bennett, Lea D.
    Wang, Yi-Zhong
    Klein, Martin
    Pennesi, Mark E.
    Jayasundera, Thiran
    Birch, David G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (02) : 332 - 337
  • [24] Macular drusenoid deposits in X-linked retinoschisis
    Tandon, Manish
    Shukla, Dhananjay
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2013, 61 (07) : 366 - U62
  • [25] Clinical and molecular characterization of females affected by X-linked retinoschisis
    Staffieri, Sandra E.
    Rose, Loreto
    Chang, Andrew
    De Roach, John N.
    McLaren, Terri L.
    Mackey, David A.
    Hewitt, Alex W.
    Lamey, Tina M.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 (07) : 643 - 647
  • [26] The Road towards Gene Therapy for X-Linked Juvenile Retinoschisis: A Systematic Review of Preclinical Gene Therapy in Cell-Based and Rodent Models of XLRS
    van der Veen, Isa
    Berzal, Andrea Heredero
    Koster, Celine
    ten Asbroek, Anneloor L. M. A.
    Bergen, Arthur A.
    Boon, Camiel J. F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [27] TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS
    Schmitt, Melanie A.
    Wang, Kevin
    DeBenedictis, Meghan J.
    Traboulsi, Elias, I
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (11): : 2176 - 2183
  • [28] Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis
    Verbakel, Sanne K.
    van de Ven, Johannes P. H.
    Le Blanc, Linda M. P.
    Groenewoud, Joannes M. M.
    de Jong, Eiko K.
    Klevering, B. Jeroen
    Hoyng, Carel B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (13) : 5143 - 5147
  • [29] Genetic analysis and clinical features of X-linked retinoschisis in Chinese patients
    Hu, Qin-Rui
    Huang, Lv-Zhen
    Chen, Xiao-Li
    Xia, Hui-Ka
    Li, Tian-Qi
    Li, Xiao-Xin
    SCIENTIFIC REPORTS, 2017, 7
  • [30] R213W mutation in the retinoschisis 1 gene causes X-linked juvenile retinoschisis in a large Chinese family
    Xu, Jun
    Gu, Hong
    Ma, Kai
    Liu, Xipu
    Snellingen, Torkel
    Sun, Erdan
    Wang, Ningli
    Liu, Ningpu
    MOLECULAR VISION, 2010, 16 (171): : 1593 - 1600